F.I. Proctor Foundation (@proctorfndn) 's Twitter Profile
F.I. Proctor Foundation

@proctorfndn

The F.I. Proctor Foundation is an internationally renowned research unit at UCSF dedicated to combating infectious and inflammatory ocular diseases.

ID: 1025100328729862144

calendar_today02-08-2018 19:25:38

38 Tweet

114 Takipçi

89 Takip Edilen

F.I. Proctor Foundation (@proctorfndn) 's Twitter Profile Photo

🚨🚨Last chance to share your thoughts on whether #azithromycin has a role in the treatment of #COVID19. We want to hear from you!

Catie Oldenburg (@catieoldenburg) 's Twitter Profile Photo

Thrilled at the shout-out for our new outpatient #COVID19 trial in San Francisco Chronicle chronicle today! The trial launched this week, more details to come here soon. sfchronicle.com/health/article…

F.I. Proctor Foundation (@proctorfndn) 's Twitter Profile Photo

The F.I. Proctor Foundation UC San Francisco is seeking participants in a trial of #azithromycin for #COVID19. The #ACTION trial is seeking research participants who have tested positive for #SARSCoV2 who are not hospitalized. Click the link below for more information. proctor.ucsf.edu/action-trial

AAO (@aao_ophth) 's Twitter Profile Photo

Americans engaged in protests are being blinded by rubber bullets. While classified non-lethal, they are not non-blinding. Join me in condemning their use. Using your voice shouldn’t mean losing your vision. #NotOneMorEye #NoRubberBullets #ThisIsOurLane ow.ly/Y4k550zZqy5

Edmund Tsui, MD (@edmundtsuimd) 's Twitter Profile Photo

Team from F.I. Proctor Foundation UC San Francisco used GoogleTrends to explore a connection between #COVID19 and ocular symptoms. Compared to prior years, searches for sore & burning #eyes increased; conjunctivitis search increases were variable based on language. #ophthalmology Ophthalmology

Anthony Solomon (@anthonywsolomon) 's Twitter Profile Photo

🆕World Health Organization (WHO) guidance on resumption of💊mass treatment, 🩺active case-finding and📱population-based surveys to #beatNTDs in the context of #COVID19 was published today: bit.ly/2ByP09B 📸Fight Trachoma

🆕<a href="/WHO/">World Health Organization (WHO)</a> guidance on resumption of💊mass treatment, 🩺active case-finding and📱population-based surveys to #beatNTDs in the context of #COVID19 was published today: bit.ly/2ByP09B

📸<a href="/ITIatlanta/">Fight Trachoma</a>
Catie Oldenburg (@catieoldenburg) 's Twitter Profile Photo

Azithromycin is one of the most commonly prescribed treatments for mild #COVID19 in outpatients. We have NO evidence of if it helps, or if this is unnecessary antibiotic use. Efficacy data would tell us if this is a good option for outpatients or if we should stop this practice.

Catie Oldenburg (@catieoldenburg) 's Twitter Profile Photo

The best part of joining our group is getting access to the #ProctorPets slack channel. We’re currently hiring a postdoc to work on #RCTs to improve child health globally. Join us!

The best part of joining our group is getting access to the #ProctorPets slack channel. We’re currently hiring a postdoc to work on #RCTs to improve child health globally. Join us!
Catie Oldenburg (@catieoldenburg) 's Twitter Profile Photo

Our #RCT of #azithromycin vs placebo for outpatient #COVID is out today in JAMA Tl;dr – azithromycin doesn’t help improve symptoms in outpatients with COVID and might make things worse, so don’t use it. 1/n jamanetwork.com/journals/jama/…

Our #RCT of #azithromycin vs placebo for outpatient #COVID is out today in <a href="/JAMA_current/">JAMA</a> 

Tl;dr – azithromycin doesn’t help improve symptoms in outpatients with COVID and might make things worse, so don’t use it. 1/n

jamanetwork.com/journals/jama/…
@EPPIcenter at UCSF (@eppicenter_ucsf) 's Twitter Profile Photo

Predicting future ocular Chlamydia trachomatis infection prevalence w/ serological, clinical, molecular, & geospatial data Christine Tedijanto Wen Solomon Aragie Hugh Sturrock Tom Jeremykeenan Ben Arnold F.I. Proctor Foundation @APHI_headquarte #geospatial #epitwitter medrxiv.org/content/10.110…

Predicting future ocular Chlamydia trachomatis infection prevalence w/ serological, clinical, molecular, &amp; geospatial data
<a href="/ctedijanto/">Christine Tedijanto Wen</a> <a href="/Solomon_Aragie/">Solomon Aragie</a> <a href="/SturrockHugh/">Hugh Sturrock</a> <a href="/Lietman/">Tom</a> <a href="/jeremykeenan52/">Jeremykeenan</a> <a href="/ben83638/">Ben Arnold</a> <a href="/proctorfndn/">F.I. Proctor Foundation</a> @APHI_headquarte
#geospatial #epitwitter 

medrxiv.org/content/10.110…
CRSN Nouna (Centre de Recherche en Santé de Nouna) (@crsnnouna) 's Twitter Profile Photo

Atelier de restitution de l'Essai clinique randomisé contrôlé en double aveugle évaluant l’efficacité, l’innocuité d’une dose d’Azithromycine versus placebo en période néonatale sur la mortalité infantile en acronyme NAITRE UC San Francisco F.I. Proctor Foundation OMS Burkina Faso INSP-Burkina Faso

Atelier de restitution de l'Essai clinique randomisé contrôlé en double aveugle évaluant l’efficacité, l’innocuité d’une dose d’Azithromycine versus placebo en période néonatale sur la mortalité infantile en acronyme NAITRE  <a href="/UCSF/">UC San Francisco</a>  <a href="/proctorfndn/">F.I. Proctor Foundation</a> <a href="/OMS_Burkina/">OMS Burkina Faso</a>  <a href="/FasoInsp/">INSP-Burkina Faso</a>